Cargando…

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells

Most normal cells express L-type amino acid transporter 2 (LAT2). However, L-type amino acid transporter 1 (LAT1) is highly expressed in many tumor cells and presumed to support their increased growth and proliferation. This study examined the effects of JPH203, a selective LAT1 inhibitor, on cell g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Dae Woo, Kim, Do Kyung, Kanai, Yoshikatsu, Wempe, Michael F., Endou, Hitoshi, Kim, Jong-Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709476/ https://www.ncbi.nlm.nih.gov/pubmed/29200902 http://dx.doi.org/10.4196/kjpp.2017.21.6.599

Ejemplares similares

Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203
por: Brunocilla, Chiara, et al.
Publicado: (2023)

Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1
por: Okanishi, Hiroki, et al.
Publicado: (2022)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
por: Häfliger, Pascal, et al.
Publicado: (2018)

LAT1 inhibitor JPH203 sensitizes cancer cells to radiation by enhancing radiation-induced cellular senescence
por: Bo, Tomoki, et al.
Publicado: (2021)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis
por: Otani, Rina, et al.
Publicado: (2023)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

The Selective LAT1 Inhibitor JPH203 Enhances Mitochondrial Metabolism and Content in Insulin-Sensitive and Insulin-Resistant C2C12 Myotubes
por: Rivera, Caroline N., et al.
Publicado: (2023)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Flavonoid compound breviscapine suppresses human osteosarcoma Saos‐2 progression property and induces apoptosis by regulating mitochondria‐dependent pathway
por: Wang, Zhijun, et al.
Publicado: (2020)

Methylation-associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC
por: Huang, Yi, et al.
Publicado: (2022)

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
por: Wempe, Michael F, et al.
Publicado: (2012)

Both Heterozygous and Homozygous Loss‐of‐Function JPH3 Variants Are Associated with a Paroxysmal Movement Disorder
por: Steel, Dora, et al.
Publicado: (2022)

Molecular Mechanism of Ochratoxin A Transport in the Kidney
por: Anzai, Naohiko, et al.
Publicado: (2010)

High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas
por: Yanagisawa, Nobuyuki, et al.
Publicado: (2014)

Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma
por: Liu, Zhuochao, et al.
Publicado: (2021)

Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure
por: Vanninen, Sari U. M., et al.
Publicado: (2018)

MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 via Targeting Caspase 8
por: Xu, Bin, et al.
Publicado: (2017)

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
por: Kaira, K, et al.
Publicado: (2008)

Expression and functional characterisation of System L amino acid transporters in the human term placenta
por: Gaccioli, Francesca, et al.
Publicado: (2015)

JPH2 Mutant Gene Causes Familial Hypertrophic Cardiomyopathy: A Possible Model to Unravel the Subtlety of Calcium-Regulated Contractility
por: Roberts, Robert
Publicado: (2017)

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
por: Ichinoe, Masaaki, et al.
Publicado: (2021)

The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity
por: Zhu, Min, et al.
Publicado: (2021)

Maternal Protein Restriction in the Rat Inhibits Placental Insulin, mTOR, and STAT3 Signaling and Down-Regulates Placental Amino Acid Transporters
por: Rosario, Fredrick J., et al.
Publicado: (2011)

Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin’s lymphoma
por: Jigjidkhorloo, Narangerel, et al.
Publicado: (2021)

KRP-203 Is a Desirable Immunomodulator for Islet Allotransplantation
por: Fathi, Ibrahim, et al.
Publicado: (2021)

L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation
por: Ito, Daiki, et al.
Publicado: (2021)

Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2
por: Kato, Takafumi, et al.
Publicado: (2022)

miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A
por: Yang, Dawei, et al.
Publicado: (2015)

Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203
por: Zhou, Xiang, et al.
Publicado: (2017)

Nelumbo nucifera Leaf Extract Induces Cytotoxicity in Osteosarcoma Saos-2 Cells
por: Britina, Gautam, et al.
Publicado: (2023)

Significance of System L Amino Acid Transporter 1 (LAT-1) and 4F2 Heavy Chain (4F2hc) Expression in Human Developing Intestines
por: Ohno, Chikara, et al.
Publicado: (2009)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Microscopic Photosensitization with Chloromethyl-X-Rosamine on a Subpopulation of Mitochondria Induces Apoptosis in Human Osteosarcoma Cells
por: Lum, Maggie, et al.
Publicado: (2001)

Retraction: miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A
Publicado: (2023)

Cell-Projection Pumping of Fibroblast Contents into Osteosarcoma SAOS-2 Cells Correlates with Increased SAOS-2 Proliferation and Migration, as well as Altered Morphology
por: Mahadevan, Swarna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_92dkiulgq1j5tednr1log6vtj9